Plurilock Announces Payment of Debenture Interest 
From Experimentation to Production – Operationalizing Enterprise AI on AWS Molecular Templates Strengthens Board of Directors and Management Team
Industry Veteran Gabriela Gruia, M.D., appointed to Board of Directors Megan Filoon promoted to General…
Ceapro Bolsters Board of Directors with Appointment of Top Executive from Global Pharmaceutical Industry
Ronnie Miller, President and CEO of Roche Canada from 2000-2022 retiring after 43 years of…
Longeveron to Present at Q1 Virtual Investor Summit Conference
MIAMI, March 02, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical…
AmMax Bio Announces Positive Phase 2 Results Demonstrating Proof-of-Concept for the Novel Local Delivery of AMB-05X in Patients with Tenosynovial Giant Cell Tumor (TGCT)
Intra-Articular Injection Strategy Shows Efficacy Across Multiple Clinical Endpoints and Favorable Safety Profile After 12…
Candel Therapeutics Appoints Seshu Tyagarajan, Ph.D., RAC, as Chief Technical and Development Officer
NEEDHAM, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Nasdaq: CADL), a late…
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics…
Owkin welcomes leading immuno-oncology professor as Chief Medical Officer and senior pharma exec as SVP Data Science
Featured Image for Owkin Featured Image for Owkin NEW YORK, March 02, 2022 (GLOBE NEWSWIRE)…
Harpoon Therapeutics Receives FDA Fast Track Designation for HPN217
SOUTH SAN FRANCISCO, Calif., March 02, 2022 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP),…
Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
Statera developing STAT-205 as novel therapy for immune modulation in treating post-acute (long-haul) patients with…
SIGA Announces Start of TPOXX® Post-Exposure Prophylactic (“PEP”) Clinical Trials
NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a…
Generation Bio to Participate in 42nd Annual Cowen Health Care Conference
CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology…
Avalo Therapeutics Reports 2021 Financial Results and Provides Business Updates
Dr. Garry Neil and Chris Sullivan promoted to Chief Executive Officer and Chief Financial Officer,…
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2021
Continued progress advancing next-generation antibody portfolio, with ongoing clinical trials evaluating the broad potential of…
Datawiza Delivers Industry’s Only No-Code Solution for B2B Single Sign-On for Multi-Tenant SaaS Vendors
No-code Datawiza platform enables SaaS vendors to support customer Single Sign-On, no matter what identity…
PandaDoc Announces Integration with QuickBooks Online Advanced
PandaDoc Connector by QuickBooks Enables Seamless Document Creation and Management for Users of Popular Accounting…
Exterro Launches Global Training Academy Across its Entire Portfolio of Legal GRC Products
Full-Time Academy Staff Will Manage In-Person, On-Demand and Live Virtual Training Courses, with New Offices…
Aptean Launches New Cloud-based Enterprise Asset Management Solution Including CMMS for Manufacturers
Aptean EAM software experience on tablet Here you see the user experience for Aptean’s Enterprise…
WonderFi Reports over 600,000 Users Across Ecosystem
Vancouver, British Columbia–(Newsfile Corp. – March 2, 2022) – WonderFi Technologies Inc. (NEO: WNDR) (OTC…
DGTL Holdings Completes Acquisition of Engagement Labs
Toronto, Ontario–(Newsfile Corp. – March 2, 2022) – DGTL Holdings Inc. (TSXV: DGTL) (OTCQB: DGTHF)…
Polaris Announces Expansion of Distribution Center in Wilmington, Ohio
Adding 165,000 square feet to support the company’s PG&A business and enhance dealer and customer…